Table 2 Outcomes of administering ketamine or etomidate before and after propensity matching
Unmatched patients | 1:3 propensity score matching patients | |||||||
|---|---|---|---|---|---|---|---|---|
Outcomes | Ketamine (n = 118) | Etomidate (n = 502) | 95% CI | Ketamine (n = 118) | Etomidate (n = 354) | 95% CI | ||
First-pass success rate, n (%) | 107 (90.7) | 448 (89.2) | (-0.13, 0.08) | 107 (90.7) | 319 (90.1) | (-0.15, 0.13) | ||
Mortality, n (%) | 19 (16.1) | 98 (19.5) | (-0.05, 0.12) | 19 (16.1) | 73 (20.6) | (-0.05, 0.15) | ||
ICU LOS, days, median (IQR) | 8 (4–15) | 8 (3–19) | (-5.13, 6.79) | 8 (4–15) | 10 (4–21) | (-6.01, 6.03) | ||
Ventilator days, median (IQR) | 4 (2–10) | 4 (2–13) | (-3.5, 3.34) | 4 (2–10) | 5 (2–13) | (-4.1, 2.9) | ||
Hospital LOS, days, median (IQR) | 24.5 (10.25–38.5) | 19 (7–38) | (-2.41, 12.23) | 24.5 (10.25–38.5) | 22 (8–40) | (-3.69, 11.15) | ||